Why the study?
To determine whether the local anesthetic levobupivacaine in combination with fentanyl or dexmedetomidine can improve the efficacy and duration of analgesia in lower extremity surgery.
Does dexmedetomidine prolong post-operative analgesia compared to fentanyl when added to levobupivacaine in patients undergoing lower extremity surgery?
Does dexmedetomidine prolong post-operative analgesia compared to fentanyl when added to levobupivacaine in patients undergoing lower extremity surgery?
Dexmedetomidine is a superior adjuvant to levobupivacaine compared to fentanyl for prolonging post-operative analgesia in lower extremity surgery.
Supports preferring dexmedetomidine over fentanyl as levobupivacaine adjuvant for extended analgesia after lower extremity surgery; confirms meta-analytic superiority.
Background: In combination with local anesthetics such as levobupivacaine, fentanyl, and dexmedetomidine improve post-operative analgesia after surgery on the lower extremities. Aims and Objectives: To determine whether the local anesthetic levobupivacaine in combination with fentanyl or dexmedetomidine can improve the efficacy and duration of analgesia in lower extremity surgery. Materials and Methods: After a search in PubMed, Google, and Web of Science, six randomized controlled trials with 400 patients were found. Review Manager 5 was then used to retrieve the study results and calculate the effect sizes. Results: The effects of 0.5% levobupivacaine with fentanyl (group F) and dexmedetomidine (group D) on sensory blockade, regression, and post-operative analgesia were investigated in numerous studies. Group D had a significant advantage in sensory regression (standard mean difference [SMD] −3.34, confidence interval [CI] [−4.07, −2.62], P<0.00001), although there was no significant difference in the onset of sensory blockade (SMD −0.21, CI [−1.28, 0.86], dexmedetomidine prolonged post-operative analgesia (SMD −7.34, CI [−11.08, −3.60], P=0.0001). The heterogeneity between the studies was substantial (I²=59–97%). The methodological excellence of the selected studies was reflected in their low risk of bias in all areas. Conclusion: Despite the identical onset of sensory blockade, dexmedetomidine prolongs sensory regression and post-operative analgesia more than fentanyl. Despite considerable variability, these results are supported by a low bias, making dexmedetomidine a better adjuvant for analgesia in chronic lower extremity surgery.
No takes yet. Share an insight, caveat, or question.
Gupta et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: